310 related articles for article (PubMed ID: 24606313)
1. Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway.
Yu Z; Yu P; Chen H; Geller HM
J Neurochem; 2014 Jul; 130(1):41-49. PubMed ID: 24606313
[TBL] [Abstract][Full Text] [Related]
2. Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway.
Yi M; Dou F; Lu Q; Yu Z; Chen H
Neurosci Lett; 2016 Jun; 624():62-71. PubMed ID: 27163196
[TBL] [Abstract][Full Text] [Related]
3. KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.
Yi M; Yu P; Lu Q; Geller HM; Yu Z; Chen H
Mol Cell Neurosci; 2016 Oct; 76():21-32. PubMed ID: 27567685
[TBL] [Abstract][Full Text] [Related]
4. The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke.
Yi M; Wei T; Wang Y; Lu Q; Chen G; Gao X; Geller HM; Chen H; Yu Z
J Neuroinflammation; 2017 Oct; 14(1):203. PubMed ID: 29037241
[TBL] [Abstract][Full Text] [Related]
5. KCa3.1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway.
Wei T; Wang Y; Xu W; Liu Y; Chen H; Yu Z
Neurobiol Dis; 2019 Dec; 132():104588. PubMed ID: 31470105
[TBL] [Abstract][Full Text] [Related]
6. Ca
Yu Z; Dou F; Wang Y; Hou L; Chen H
J Neuroinflammation; 2018 Nov; 15(1):316. PubMed ID: 30442153
[TBL] [Abstract][Full Text] [Related]
7. RGMa mediates reactive astrogliosis and glial scar formation through TGFβ1/Smad2/3 signaling after stroke.
Zhang R; Wu Y; Xie F; Zhong Y; Wang Y; Xu M; Feng J; Charish J; Monnier PP; Qin X
Cell Death Differ; 2018 Aug; 25(8):1503-1516. PubMed ID: 29396549
[TBL] [Abstract][Full Text] [Related]
8. Astrocyte-Derived Estrogen Regulates Reactive Astrogliosis and is Neuroprotective following Ischemic Brain Injury.
Wang J; Sareddy GR; Lu Y; Pratap UP; Tang F; Greene KM; Meyre PL; Tekmal RR; Vadlamudi RK; Brann DW
J Neurosci; 2020 Dec; 40(50):9751-9771. PubMed ID: 33158962
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of KCa3.1 suppresses TGF-β1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways.
Huang C; Day ML; Poronnik P; Pollock CA; Chen XM
Int J Biochem Cell Biol; 2014 Feb; 47():1-10. PubMed ID: 24291552
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular calcification by block of intermediate conductance calcium-activated potassium channels with TRAM-34.
Freise C; Querfeld U
Pharmacol Res; 2014 Jul; 85():6-14. PubMed ID: 24813858
[TBL] [Abstract][Full Text] [Related]
11. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
12. STAT3-mediated astrogliosis protects myelin development in neonatal brain injury.
Nobuta H; Ghiani CA; Paez PM; Spreuer V; Dong H; Korsak RA; Manukyan A; Li J; Vinters HV; Huang EJ; Rowitch DH; Sofroniew MV; Campagnoni AT; de Vellis J; Waschek JA
Ann Neurol; 2012 Nov; 72(5):750-65. PubMed ID: 22941903
[TBL] [Abstract][Full Text] [Related]
13. Blockade of KCa3.1 ameliorates renal fibrosis through the TGF-β1/Smad pathway in diabetic mice.
Huang C; Shen S; Ma Q; Chen J; Gill A; Pollock CA; Chen XM
Diabetes; 2013 Aug; 62(8):2923-34. PubMed ID: 23656889
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of KCa3.1 promotes human airway smooth muscle cell phenotypic modulation.
Yu ZH; Wang YX; Song Y; Lu HZ; Hou LN; Cui YY; Chen HZ
Pharmacol Res; 2013 Nov; 77():30-8. PubMed ID: 24055799
[TBL] [Abstract][Full Text] [Related]
15. KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling Pathways.
Yu Z; Yi M; Wei T; Gao X; Chen H
Front Cell Neurosci; 2017; 11():319. PubMed ID: 29075181
[TBL] [Abstract][Full Text] [Related]
16. The Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer's Disease.
Wei T; Yi M; Gu W; Hou L; Lu Q; Yu Z; Chen H
Front Pharmacol; 2016; 7():528. PubMed ID: 28105015
[TBL] [Abstract][Full Text] [Related]
17. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
Chen CL; Liao JW; Hu OY; Pao LH
Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
[TBL] [Abstract][Full Text] [Related]
18. Selective deletion of apolipoprotein E in astrocytes ameliorates the spatial learning and memory deficits in Alzheimer's disease (APP/PS1) mice by inhibiting TGF-β/Smad2/STAT3 signaling.
Zheng JY; Sun J; Ji CM; Shen L; Chen ZJ; Xie P; Sun YZ; Yu RT
Neurobiol Aging; 2017 Jun; 54():112-132. PubMed ID: 28366226
[TBL] [Abstract][Full Text] [Related]
19. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
D'Alessandro G; Catalano M; Sciaccaluga M; Chece G; Cipriani R; Rosito M; Grimaldi A; Lauro C; Cantore G; Santoro A; Fioretti B; Franciolini F; Wulff H; Limatola C
Cell Death Dis; 2013 Aug; 4(8):e773. PubMed ID: 23949222
[TBL] [Abstract][Full Text] [Related]
20. KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis.
Huang C; Shen S; Ma Q; Gill A; Pollock CA; Chen XM
Nephrol Dial Transplant; 2014 Feb; 29(2):313-24. PubMed ID: 24166472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
